Mots-clés
> MYOBASE > INFORMATION-COMMUNICATION > communication > événement > colloque
colloqueSynonyme(s)abstract ;acte de colloque ;conférence ;congrès ;journée ;séminaire ;work shop ;workshop ;rencontre symposium |
Documents disponibles dans cette catégorie (3070)
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Eisenberg I ; Eran A ; Lidov HG ; Kang PB ; Kohane IS ; Kunkel LM | 2008The muscular disorders are a heterogeneous group of over thirty different inherited diseases characterized by muscle wasting and progressive weakness of variable distribution and severity, resulting in significant morbidity and disability. Altho[...]Article
Distribution of ribonucleoprotein complexes in cajal bodies from SMA type i-derived fibroblast cells
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Renvoisé B ; Lefebvre S | 2008Spinal Muscular Atrophy (SMA) is a common neurodegenerative disease caused by reduced levels of the Survival Motor Neuron (SMN) protein. SMN is part of a large ubiquitous protein complex that concentrates in nuclear gems/Cajal bodies (CBs) and p[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Blumen SC ; Israeli D ; Robin V ; Astord S ; Barkats M ; Vignaud L ; Porte F ; Achiron A ; Carasso RL ; Gurevich M ; Braverman I ; Blumen N ; Viollet L | 2008Distal hereditary motor neuronopathies form a heterogeneous group of rare inherited lower motor neuron disorders. Autosomal recessive inheritance has been reported in six subtypes (dHMN III, IV, VI, Jerash type). We studied a large inbred Israel[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Guy-Coichard C | 2008A l'aube de la thérapie génique et des procédés curatifs spécifiques, la douleur dans les MNM reste peu évoquée et étudiée dans la littérature. Ce constat contraste avec le témoignage des malades et la pratique des soignants prenant en charge ce[...]Article
Trinh-Duc A ; Santin A ; Sureau C ; Bagou G ; Charpentier S ; Couvreur J ; Fougeras O ; Miranda J ; Philippe JM ; Perrier C ; Raphaël V ; Le Gall C | 2008Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Berardinelli A ; Orcesi S ; Rossi M ; Motta C ; Gorni K ; Balottin U | 2008Duchenne muscular dystrophy (DMD) is an X-linked progressive neuromuscular disorder due to lack of Dystrophin protein in muscle. Dystrophin is mainly concentrated in skeletal and cardiac muscle and less in smooth muscle, its deficiency causing s[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Ferreiro V ; Giliberto F ; Muniz Garcia N ; Francipane L ; Marcese D ; Roque M ; Frechtel G ; Szijan I | 2008The severe Duchenne muscular dystrophy (DMD) and the milder Becker muscular dystrophy (BMD) are characterized by progressive muscular degeneration. Both are caused by mutations in the dystrophin gene (Xp21.2). Two thirds of patients show intrage[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Sblendorio V ; Palmieri B ; Ferrari A ; Pietrobelli A | 2008Abstract. Duchenne muscular dystrophy yields pervasive and progressive muscle mass loss. In the current measures relating to the monitoring of disease progression is relevant: 1) the type of scale used; 2) the clinical significance of the at[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Bitoun M ; Prudhon B ; Durieux AC ; Bevilacqua JA ; Romero NB ; Guicheney P | 2008The autosomal dominant centronuclear myopathy (CNM) is a rare congenital myopathy characterized by delayed motor milestones, facial and muscular weakness often associated with bilateral ptosis. The typical muscle histopathology comprises central[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Benard R ; Dupas B ; Tadayoni R ; Sene A ; Roux MJ ; Nudel U ; Yaffe D ; Sahel JA ; Rendon A | 2008Dp71 is the most abundant Duchenne Muscular Dystrophy (DMD) gene product expressed in the retina. This protein in the Müller glial cells (MGC) plays a role in regulating the retinal homeostasis by clustering Kir4.1 and AQP4 channels. (see poster[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Avril-Delplanque A ; Mercier S ; Daoud F ; Nusbaum P ; Leturcq F ; Kaplan JC ; Dreyfus P ; Chelly J ; Garcia L | 2008Duchenne Muscular Dystrophy (DMD) is the most severe form of dystrophinopathy, in which nul mutations in the DMD gene (mostly frameshifting deletions, and nonsense point mutations) result in the complete absence of dystrophin. A milder phenotype[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Desguerre I ; Poron F ; Barbet P ; Gherardi R ; Christov C | 2008In DMD, repeated cycles of acute myofiber necrosis and regeneration progressively lead to severe terminal myofiber degeneration and extensive fibrosis. A preliminary analysis of 39 muscle biopsies from DMD patients at different ages allowed roug[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Eagle M ; Scott E | 2008Le réseau North Star Clinical Network for Paediatric Neuromuscular Disease Management (NSCN) est une collaboration entre centres neuromusculaires du Royaume-Uni dont l'objectif est d'optimiser la prise en charge des enfants atteints de troubles [...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Finkel R | 2008L'échelle idéale pour l'évaluation d'un patient atteint d'un trouble neuromusculaire intègre des éléments significatifs du point de vue fonctionnel, peut être mise en œuvre rapidement et sans équipement onéreux, par des évaluateurs formés, est s[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Mercuri E | 2008Au cours des années passées, l'intérêt pour les échelles fonctionnelles et les autres méthodes d'évaluation de la fonction musculaire et de la force dans les troubles neuromusculaires n'a cessé d'augmenter. Une gamme de bonnes méthodes de mesure[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Pandya S ; Fox D ; Ciafaloni E ; Druschel C ; Moxley R | 2008Objective : To determine the effect of age at initiation of corticosteroids on age at loss of ambulation in patients with Duchenne muscular dystrophy (DMD) Background : The hypothesis among clinicians is that earlier the initiation of corticoste[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Briguet A ; Erb M ; Courdier-Fruh I ; Barzaghi P ; Santos G ; Herzner H ; Lescop C ; Siendt H ; Henneboehle M ; Weyermann P ; Magyar J ; Dubach-Powell J ; Metz G ; Meier T | 2008Dystrophin deficiency is the underlying molecular cause of progressive muscle weakness observed in Duchenne muscular dystrophy (DMD). Loss of functional dystrophin leads to elevated levels of intracellular Ca2+, a key step in the cellular pathol[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Rauscent H ; Bérard C ; Humbertclaude V ; Gautheron V ; Richelme C | 2008Concerning multidisciplinary care of Duchenne Muscular Dystophy (DMD), the prevention of scoliosis remains a priority. Spinal surgery is considered as the treatment of choice and early instrumentation and fusion are widely proposed. The objectiv[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Rosemblatt M ; Yu H ; de la Porte S | 2008INTRODUCTION A strategy for treating Duchenne muscular dystrophy (DMD) is to compensate for the absence of dystrophin by up-regulation of utrophin, a homologous cytoskeletal protein. OBJECTIFS One potential approach to up-regulate utrophin expre[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Turin E ; Hoff H ; Gatti F ; Winders T ; Singh R ; Starke J ; Rutter J ; Bledsoe C ; Lavin J ; Palmieri B ; Carlson CG | 2008Ursodeoxycholic acid (UDCA) is in current clinical use for the treatment of biliary cirrhosis and has been shown to reduce nuclear p65 activation in HeLa cells expressing elevated glucocorticoid receptor (Miura et al., J. Biol. Chem., 276(50), 4[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Jamart C ; An GL ; Francaux M ; Raymackers JM | 2008INTRODUCTION Des situations physiologiques et pathologiques entraînent la mise en décharge du muscle et provoquent perte de poids et de fonctionnalité. Le système ubiquitine-protéasome semble jouer un rôle dans ces modifications. OBJECTIFS Nous [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Steffensen B ; Mayhew A ; Aloysius A ; Eagle M ; Mercuri E ; Messina S ; Mazzone E ; Nadeau A ; Main M ; Scott E ; Werlauff U ; Werge B ; Glanzmann A ; Muntoni F | 2008The EK scale was developed as a clinical tool to assess functional ability and to determine the need for and impact of intervention in the non-ambulatory stages of Duchenne muscular dystrophy (DMD) and in spinal muscular atrophy (SMA). EK is a c[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Steffensen BF ; Mayhew A | 2008L'échelle EK a d'abord été développée comme outil clinique d'évaluation de la capacité fonctionnelle, pour déterminer la nécessité d'une intervention et évaluer les résultats de l'intervention chez des personnes atteintes de la dystrophie muscul[...]Article
Livre
Pereon Y, Auteur ; Magistris MR ; Raharijaona M ; Houlgatte R ; Camdessanché JP ; Attarian S ; Pouget J ; Viala K ; Magy L ; Danziger N ; Cassim F ; Boutry N ; Bouche P ; Séror R ; Baron D ; Psimaras P ; Ebelin M ; Truffert A ; Kurth I ; Libbrecht D ; Wang FC ; Mussini JM ; Pitt M ; Renault F ; Pereon Y ; Valls-Solé J ; Fournier E ; Labarre-Vila A ; Jabre JF ; Labat JJ ; Riant T ; Rigaud J ; Lefaucheur JP ; Raint R ; Guérineau M ; Robert R ; Maisonobe T ; Léger JM ; Larue S ; Dashi F ; Musset L ; Neil J ; Caillon F ; Magot A ; Soichot P ; Chauplannaz G ; Vial C ; Ochsner F ; Novy J ; Kuntzer T ; Nicolas G ; Petiot P ; Demeret S | Solal | 2008Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Nivet AL ; Plancheron A ; Lustremant C ; Peschanski M ; Monville C | 2008Duchenne muscular dystrophy (DMD) is a genetic disease with an X-linked recessive pattern of inheritance. It affects one in 3,500 boys at birth. Muscular dystrophies are caused by mutation of the same gene encoding for the dystrophin. This prote[...]Rapport institutionnel
Article
Le premier Colloque "Défi de civilisation" sur le thème : "le handicap, enjeu de civilisation ?" s'est déroulé le 3 décembre 2007 au musée du quai Branly à Paris. Au programme : Trois tables rondes se sont réunies sur les sujets suivants : - L'h[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Pasalidou P ; Richelme C ; Destombe S ; Triolo V ; Hardion M | 2008INTRODUCTION L'enfant atteint de maladie neuromusculaire est particulièrement exposé au risque de dénutrition. Très peu d'études se sont intéressées à leur état nutritionnel. OBJECTIFS Évaluation de la dénutrition chez les enfants atteints de ma[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Doglio L ; Pernigotti I ; Tacchino C ; Pedemonte M ; Scapolan S ; Minetti C | 2008DMD patients walk with a non-physiological pattern showing a initially weakness of antigravitary muscles, followed by loss of walking capability. Initially, DMD patients do not show clinical signs of pathological pattern, that become manifest wi[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Belicchi M ; Meregalli M ; Razini P ; Cattaneo A ; Farini A ; Iacchetti E ; Porretti L ; Milani P ; Bresolin N ; Torrente Y | 2008The use of stem cells in regenerative medicine and cell-based therapies offers immense potential in diseases witch have currently no treatment such as Duchenne muscular dystrophy. A limitation to the use of CD133+ for a therapeutic application i[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Rahbek J | 2008La plupart des cliniciens, chercheurs, avocats de la santé, responsables politiques, et même les tiers payants sont d'accord - d'un point de vue conceptuel - pour dire que la mesure de la QdV est une considération importante dans l'évaluation de[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Rahbek J | 2008Most clinicians, researchers, health care advocates, policy makers, and even third-party payers agree - on a conceptual level - that the measurement of QoL is an important consideration in evaluating the effectiveness of medical rehabilitation i[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Chopard A ; Bronicki L ; Hillock S ; Lunde J ; Jasmin BJ | 2008Several transcriptional mechanisms are known to be involved in the atrophic-hypertrophic response of skeletal muscle. However, converging lines of evidence have led us to hypothesize that post-transcriptional events, operating at the level of mR[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Daniele N ; Laure L ; Suel-Petat L ; Roudaut C ; Ouali A ; Bartoli M ; Richard I | 2008INTRODUCTION Les dystrophies musculaires sont des maladies génétiques caractérisées par une dégénérescence musculaire progressive. L'atrophie fréquemment associée à ces pathologies participe à la perte de force du tissu musculaire. OBJECTIFS Not[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Gallais B | 2008La fatigue est une plainte psychophysiologique fréquemment exprimée dans les pathologies neuromusculaires. Que ce soit dans sa dimension physiologique ou sa dimension subjective, la fatigue doit être évaluée et prise en compte par les rééducateu[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Millet GY ; Féasson L | 2008La fatigue figure parmi les symptômes les plus fréquemment revendiqués lors d'une première consultation neuromusculaire, cependant son origine et les mécanismes responsables de son apparition sont particulièrement diversifiés. Ce phénomène psych[...]Livre
Ce colloque organisé en partenariat avec l'Association Française contre les Myopathies (AFM) et la Caisse Nationale de Solidarité pour l'Autonomie (CNSA) aborde en première partie les connaissances socio-historiques et épidémiologiques sur les u[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Sakthivel M ; Lakshmi R ; Thilothammal N ; Viswanathan V | 2008A 10-year-old female child presented with 2-year history of progressive difficulty in walking and getting up from supine posture. Clinical evaluation, serum creatine phosphokinase levels (2222 IU/L) and muscle biopsy was consistent with muscular[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Baranov VS ; Vakharlovsky VG ; Komantzev V ; Malysheva OV ; Kiselev AV | 2008The results of prolonged valproic acid (VA) treatment of 13 patients affected with proximal spinal muscular atrophy (SMA) are summarized. Positive clinical response was registered in 10 out of 13 SMA patients. Some minor clinical progress was re[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Sene A ; Fort PE ; Forster V ; Mornet D ; Nudel U ; Yaffe D ; Sahel JA ; Rendon A | 2008We have showed that Dp71 and Utrophin are the only dystrophin superfamily members expressed in Müller Glial cells (MGC). Dp71 deletion leads to a compensating utrophin up-regulation Here we characterized the Dp71 or Utrophin /Dystrophin Associat[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Gautheron V | 2008An assessment of functional capacity is essential before starting any rehabilitation treatment and is a prerequisite if compensatory strategies and technical aids are to be suggested to patients. The Functional Independence Measure (FIM™) was pu[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Fleischmann BK | 2008We have assessed in recent years the utility of different types of progenitors/stem cells for cardiac repair after myocardial infarction. One of the key questions was whether infarcted heart tissue can determine the differentiation fate of engra[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Burghes A ; Workman E ; McGovern V ; Saieva L ; Pellizzoni L ; Beattie C | 2008Spinal muscular atrophy is caused by loss or mutation of the SMN1 gene and retention of SMN2, leading to low levels of functional SMN. A major function of SMN is assembly of the heptameric Sm ring onto snRNA with SMA tissues having reduced activ[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Junion G ; Bataillé L ; Jagla T ; Da Ponte JP ; Tapin R ; Jagla K | 2008Correct diversification of cell types during development is controlled by combinatorial code of transcription factor activities, the identity gene code. The role of identity genes in specifying cell fates has been demonstrated in a broad range o[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Apostol P ; Cimponeriu D ; Toma M ; Butoianu N ; Burloiu C ; Craiu D ; Magureanu S ; Gavrila L | 2008Vitamin D is a steroid hormone known for its key roles in calcium homeostasis, proliferation and apoptosis. Previous studies have also reported the association of vitamin D deficiency with muscle weakness and neuromuscular dysfunction. The vitam[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Melki J | 2008Motor neuron diseases (MND) are rare diseases characterized by degeneration of lower (spinal muscular atrophy, SMA), upper (spastic paraplegia, HSP and primary lateral sclerosis) or both upper and lower motor neurons (amyotrophic lateral scleros[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Basak AN | 2008ALS is the most common adult-onset motor neuron disease. Described in 1869, by the French Neurobiologist J. M. Charcot, the primary disease hallmark is the selective and progressive degeneration of the neurons in the corticospinal tracts. ALS pr[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Laing NG | 2008The congenital myopathies are a diverse group of entities, with considerable genetic heterogeneity. The genetic heterogeneity includes mutations in multiple different genes causing similar pathological phenotypes, and multiple different patholog[...]Article
Livre
Nuss M, Auteur ; Agthe C, Collaborateur ; Ancet P, Collaborateur ; De Vries N, Collaborateur ; Dreyer P, Collaborateur ; Fumagalli L, Collaborateur ; Gelly C, Collaborateur ; Griffo G, Collaborateur ; Parisot AS, Collaborateur ; Stiker HJ, Collaborateur ; Siegrist D, Collaborateur ; Stickel M, Collaborateur | Dunod | 2008Nos sociétés ont par rapport à la question de la sexualité des personnes handicapées une position paradoxale. Alors qu'on ne cesse de proclamer le droit des personnes dépendantes à l'égalité des chances dans tous les domaines, on peine encore à [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Belayew A | 2008Facioscapulohumeral muscular dystrophy (FSHD) is considered a disorder of gene regulation. The pathological deletions contract the D4Z4 repeat array in the 4q35 subtelomeric region from 11 -150 units in healthy individuals down to 1-10 units in [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Chien KR | 2008The heart is composed of diverse cell types: cardiac muscle, smooth muscle, conduction system, endothelial, valvular, and interstitial mesenchymal fibroblasts. Embryonic heart field precursors, marked by the expression of the isl1+ LIM homeodoma[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Peschanski M | 2008In a preliminary study published 8 years ago (Bachoud-Lévi et al., The Lancet 2000) we showed encouraging results of transplantations of foetal neuroblasts to the brain of patients with Huntington's Disease. Four out of the 5 grafted patients ex[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Acharjee S ; Friesen W ; Tomizawa Y ; Baiazitov R ; Lee S ; Nadarajan T ; Moon YC ; Sweeney L ; Welch EM | 2008PTC Therapeutics, Inc. (PTC) and Parent Project Muscular Dystrophy (PPMD) are collaborating to discover new drugs to treat Duchenne muscular dystrophy (DMD). Several targets were selected to enter the drug discovery program based on functional v[...]Article
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Maxim D ; Otelea D | 2008DMD and BMD are transmitted as an X-linked recessive traits. Risks include a family history of DMD and BMD. Bayesians’ analysis may be used antenatally when DNA testing is uninformative or inconclusive .We report the family cases where the affec[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Miranda R ; Sébrié C ; Degrouard J ; Jaillard D ; Laroche S ; Vaillend C | 2008Mdx mice provide a model of the human X-linked muscular dystrophy (DMD) caused by mutations in the DMD gene inducing absence of 427-KDa cytoskeletal protein dystrophin. Not only expressed in muscle fibers, dystrophin is also present in the posts[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Singh R ; Samadi A ; Carlson CG | 2008Although several reports indicate that dystrophic muscle exhibits elevated nuclear p65 activation, little is known regarding the disposition of the alternative pathway in dystrophic muscle. In nondystrophic muscle, several of the components of t[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Singh R ; Millman G ; Polisiakeiwicz L ; Turin E ; Sumski C ; Samadi A ; Carlson CG | 2008The development of more efficacious treatments for Duchenne and related muscular dystrophies would be facilitated by an improved understanding of the mechanism which promotes enhanced nuclear p65 activation in dystrophic skeletal muscle. To acco[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; André E ; Hodgkinso I ; Fontaine-Carbonnel S ; Vuillerot C ; Braillon P ; Bérard C | 2008INTRODUCTION Les corticostéroïdes (CS) entraînent habituellement une fonte musculaire et une adiposité. Ils sont cependant efficaces dans la dystrophie musculaire de Duchenne (DMD) pour améliorer la force musculaire. OBJECTIFS Afin de mieux comp[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Legendre C ; Noël M | 2008La notion d'interface sera ici considérée en tant que " dispositif permettant à une personne déficiente d'interagir avec son environnement ". En premier lieu, nous abordons ce qu'est, d'une façon générale, ce dispositif d'interaction que nous ap[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Di Giorgio F ; Carrasco M ; Siao MC ; Maniatis T ; Eggan K | 2008Here we report an in vitro model system to study the molecular and cellular mechanisms that underlie the neurodegenerative disease Amyotrophic Lateral Sclerosis (ALS). Embryonic stem (ES) cells derived from mice carrying transgenic alleles of t[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Mitchell KJ ; Sassoon D ; Marazzi G | 2008Non-satellite cells are known to possess myogenic potential and can participate in muscle regeneration, however, their precise position, origin and relationship to satellite cells remain unclear. During postnatal growth, PW1/Peg3, a gene co-expr[...]Article
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Pinset C | 2008The general objective of cell therapy techniques is to replace population of deficient cells to restore the functions of damaged tissue due to disease or traumatism. Cell therapy technologies and methods have already beed developed for muscle di[...]Livre
Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Schabanel JC | 2008Préambule : La rééducation respiratoire instrumentale, si son apparition est ancienne (1975) il faut attendre les années 1998-2002 pour être reconnue. De plus son enseignement en France est encore très précaire par rapport à d'autres spé[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Beroud C ; Hamroun D ; Desmet FO ; Lalande M ; Tuffery-Giraud S ; Humbertclaude V ; Collod-Béroud G ; Claustres M | 2008The development of new genotype based therapeutic approaches has reinforced the interest about Locus Specific Databases (LSDB). This field is a crossroad of bioinformatics, genetics, clinics and research and many initiatives have been developed [...]Article
Laminopathies include a wide range of heterogeneous diseases involving different tissues, ranging from isolated peripheral neuropathies to systemic, premature aging diseases as Hutchinson-Gilford Progeria. Since the first involvement of the LMNA[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Pouget J | 2008Amyotrophic Lateral Sclerosis (ALS) remains an intriguing neurodegenerative disorder and we do net yet understood its pathogenesis. The discovery of the Cu, Zn superoxyde dismutase gene (SOD1) mutation in 20% of familial cases dramatically modif[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Bartoli M ; Gicquel E ; Barrault L ; Soheili T ; Malissen M ; Malissen B ; Udd B ; Danos O ; Richard I | 2008Limb girdle muscular dystrophy type 2D (LGMD2D, OMIM600119) is a genetic progressive myopathy that is caused by mutations in the human ?-sarcoglycan gene (SGCA). We introduced in mice the most prevalent LGMD2D mutation, R77C. Unexpectedly, we ob[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Worman HJ | 2008Cardiac disease is a prominent feature of Emery-Dreifuss muscular dystrophy (EDMD), with the initial presentation being atrioventricular conduction block followed by dilated cardiomyopathy. Autosomal dominant EDMD and related cardiomyopathies ar[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Freyssenet D | 2008La régulation de la masse musculaire est essentielle à l'homéostasie de l'organisme en permettant son adaptation à des contraintes environnementales, nutritionnelles ou pathologiques. La masse musculaire est largement régulée par des voies de si[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Rose MR | 2008There are several motivations for the increasing interest in assessing quality of life (QoL) in chronic long term conditions such as neuromuscular disease (NMD). Many NMDs are not treatable, and even those that are may have persistent morbidity [...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Bérard C ; Payan C ; Groupe d'étude MFM | 2008Suite à l'envoi d'un questionnaire en 1998 à des équipes internationales quant au besoin d'une nouvelle échelle fonctionnelle adaptée aux maladies neuromusculaires, la Mesure de Fonction Motrice (MFM) été construite et validée. Trois versions su[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Gautheron V | 2008L'évaluation des capacités fonctionnelles est fondamentale pour la conduite des actes de rééducation-réadaptation, et indispensable pour la définition des moyens de compensation et des aides techniques à proposer aux patients. La Functional Inde[...]Livre
Article
Bérard C | 2008La Mesure de la Fonction Motrice (MFM) est validée pour estimer l’évolution des capacités motrices des patients atteints de maladies neuromusculaires. La MFM est traduite en plusieurs langues (français, espagnol, anglais et portugais). La MFM do[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Spitali P ; Fabris M ; Falzarano S ; Sabatelli P ; Bovolenta M ; Neri M ; Martoni E ; Tuffery-Giraud S ; Claustres M ; Cuisset J ; Gualandi F ; Rimessi P ; Ferlini A | 2008Exon skipping by antisense oligonucleotides (AONs) represents a promising tool successfully used for reframing dystrophin as demonstrated in a recent pilot trial in DMD patients. Since all the effort has been focused on favourable exons skipping[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Laporte J ; AlQusairi J ; Boehm J ; Buj Bello A ; Hnia K ; Jamet T ; Kretz C ; Nicot AS ; Tosch V ; Toussaint A ; Mandel JL | 2008Centronuclear (myotubular) myopathies (CNM) are characterized by muscle weakness and abnormal centralisation of nuclei in muscle fibres, which does not appear secondary to regeneration. The severe neonatal X-linked form (myotubular myopathy, XLC[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Saillour Y ; Mercier S ; Avril-Delplanque A ; Daoud F ; Nusbaum P ; Leturcq F ; Kaplan JC ; Dreyfus PA ; Cossee M ; Garcia L ; Bienvenu T ; Chelly J | 2008Duchenne Muscular Dystrophy (DMD) is the most severe form of dystrophinopathy, in which null mutations in the DMD gene (mostly frameshifting deletions, and nonsense point mutations) result in the complete absence of dystrophin. A milder phenotyp[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Benhassine T ; Hamadouche T ; Assami S ; Makri S ; Chaouch M ; Tazir M | 2008Proximal spinal muscular atrophy (SMA) are a group of motor neuropathies characterized by the degeneration of spinal montoneurons leading to muscular paralysis with muscular atrophy. They are the second most fatal autosomal recessive disease, wi[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Wan L ; Kasim M ; Wang C ; Cho S ; Bachorik J ; Cho Y ; Dreyfuss G | 2008The SMN complex, comprised of the survival of motor neurons (SMN) protein and the Gemins, plays a central role in cellular RNA metabolism. The SMN complex is essential in all cells and functions as a molecular assembly machine for the biogenesis[...]Article
The Pompe Disease Diagnostic Working Group ; Winchester B ; Bali D ; Bodamer OA ; Caillaud C ; Christensen E ; Cooper A ; Cupler EJ ; Deschauer M ; Fumic K ; Jackson M ; Kishnani P ; Lacerda L ; Ledvinova J ; Lugowska A ; Lukacs Z ; Maire I ; Mandel H ; Mengel E ; Muller Felber W ; Piraud M ; Reuser A ; Rupar T ; Sinigerska I ; Szlago M ; Verheijen F ; van Diggelen OP ; Wuyts B ; Zakharova E ; Keutzer J | 2008Accès au résumé PubMed / to PubMed abstractArticle
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Sifi Y ; Sifi K ; Bestandji K ; Boulefkhad A ; Abadi N ; Benlatreche C ; Hamri A | 2008Introduction: Spinal muscular atrophy (SMA) is one of the most common autosomal recessive disorders, characterized by degeneration of anterior horn cells in the spinal cord, and leads to progressive muscular weakness and atrophy In the present s[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Tintignac LA ; Leibovitch SA ; Leibovitch MP ; Lagirand-Cantaloube J ; Csibi A ; Batonnet Pichon S | 2008INTRODUCTION The control of muscle cell size is balanced between protein synthesis and degradation. The muscle specific ubiquitine ligase Atrogin-1 is associated to pathology ranking from immobilisation, to sepsis, cancer and HIV. OBJECTIVE Atro[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Galan L ; Vela A ; Guerrero A ; Taxonera C ; Matias-Guiu J | 2008INTRODUCTION Inflammatory Bowel Disease (IBD) presents many neurological complications. Up to 3% of patients with IBD have neurological involvement (Thromboembolic phenomena, myelopathy, myopathy, multiple sclerosis and various neuropathies). Ju[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Mouisel E ; Hourde C ; Vignaud A ; Butler Browne G ; Ferry A | 2008Aging results in a deterioration of muscle structure and function in dystrophic mdx mice lacking dystrophin. In the present study we wanted to know whether this aggravation is associated with an age related decline in regenerative capacity. Both[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Vulin A ; Barthelemy I ; Goyenvalle A ; Lorain S ; Thibaud JL ; Bertoldi D ; Carlier P ; Dreyfus P ; Danos O ; Blot S ; Garcia L | 2008Duchenne Muscular Dystrophy (DMD) is an X-linked recessive disorder due to mutations in the gene encoding dystrophin. Most of mutations consist in large deletions, although their size is not correlated with the severity of the phenotype. Out-of-[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Vulin A ; Barthelemy I ; Dreyfus P ; Blot S ; Garcia L | 2008Duchenne Muscular Dystrophy (DMD) is an X-linked recessive disorder due to mutations in the gene that encodes dystrophin. Most of these mutations consist in large genomic deletions, although their extent is not directly correlated with the sever[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Laurent E ; Borel P ; Hogrel JY ; Bousquet N ; Fougerousse F ; Stockholm D ; Calpain Study Group | 2008In the Natural History of Calpainopathies study (F Fougerousse's communication), 37 patients were subjected to Computed Tomography (CT) scans of lower limbs at the beginning of the investigation and 2 years later. The objective was to quantify m[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Graham K ; Singh R ; Millman G ; Malnassy G ; Berge J ; Gatti F ; Carlson CG | 2008Hydroxyproline assays were used to assess developmental changes in fibrosis in mdx and nondystrophic mice. In both adult nondystrophic and mdx mice, hydroxyproline levels (?g hydroxyproline/mg wet weight) were significantly higher in the costal [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Maciotta S ; Meregalli M ; Farini A ; Belicchi M ; Parolini D ; Bresolin N ; Torrente Y | 2008DMD is caused by frameshift mutations in the gene encoding for dystrophin. These mutations are responsible for the loss of function of the dystrophin protein that leads to membrane destabilization and subsequent activation of pathophysiological [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Vilquin JT ; Marolleau JP ; Hagège A ; Larghero J ; Schwartz K ; Menasché P | 2008Cell grafting is a potential approach to improve cardiac healing and limit the progression of heart failure, which is characterized by a rapid and irreversible loss of cardiomyocytes. Many cell types have been tested. Myoblasts, being skeletal m[...]Livre
Vous pouvez consulter les "temps forts" du congrès et les posters sur le site de de Myology 2008Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Oldfors O | 2008Myopathies which primarily affect the thick filament protein myosin may be hereditary or aquired. Hereditary myosin myopathies are a newly emerged group of diseases caused by mutations in skeletal muscle myosin heavy chain (MyHC) genes. The phen[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Chelh I ; Meunier B ; Picard B ; Reecy J ; Chevalier C ; Hocquette JF ; Cassar-Malek I | 2008Myostatin (MSTN), a member of the TGF-beta superfamily, is a negative regulator of skeletal muscle mass. Inactivating mutations of the MSTN gene are responsible for the development of a hypermuscular phenotype in mice (McPherron et al., 1997) an[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Urtizberea JA ; De Munain LA ; Mignard C ; Boué P ; Doppler V ; Hogrel JY ; Stockholm D ; Payan C ; Poza J ; Bousquet N ; Richard I ; Fougerousse F ; Calpain Study Group | 2008The determination of the natural history is a prerequisite to any future clinical trial in a given myopathy. This is particularly true in calpainopathy where the individual disease progression may markedly vary and where the course itself seems [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Hirn C ; Shapovalov G ; Roulet E | 2008Duchenne Muscular dystrophy (DMD) is manifested by the absence of dystrophin – a structural, cytoskeletal protein – leading to muscle degeneration. Whereas the rise of cytosolic Ca2+ concentration has been extensively documented in the muscle of[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Shafey D ; Liu H ; Bowerman M ; Kothary R | 2008Spinal muscular atrophy (SMA) is the most common genetic disease resulting in infant mortality. SMA manifests itself due to a severe loss of ?-motor neurons and is caused by mutations or deletions of the ubiquitously expressed survival motor neu[...]Article
Collectif ; Léger JM ; Merkies IS ; van den Bergh P ; van Schaik IN | 2008Accès au résumé PubMed / to PubMed abstractArticle
Mercuri E, Auteur ; Mayhew A ; Muntoni F ; Messina S ; Straub V ; van Ommen GJ ; Voit T ; Bertini E ; Bushby K | 2008Report of three expert workshops - TREAT-NMD/ENMC workshop on outcome measures 12th-13th May 2007 Naarden The Netherlands; - TREAT-NMD workshop on outcome measures in experimental trials for DMD 30th June-1st July 2007 Naarden The Netherlands[...]Article
International workshop : Glycosylation defects in muscular dystrophies - Enhancing glycosylation to fight muscle diseases (15-16 May, 2008; Charlotte, USA) ; Chan YM ; Brown S ; Lu Q | 2008Accès au résumé PubMed / to PubMed abstractArticle
First International "Institute of Myology Workshop" on Facioscapulohumeral Muscular Dystrophy (May 22, 2007; Paris) ; Leterrier F ; Voit T | 2008Accès au résumé PubMed / to PubMed abstractArticle
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Hnia K ; Gayraud G ; Lacampagne A ; Koechlin C ; Hugon G ; Rivier F ; de la Porte S ; Mornet D ; Matecki S | 2008L-Arginine was proposed as a potential pharmacological tool in Duchenne muscular dystrophy (DMD), a progressive-muscle wasting disease due to mutations in the dystrophin gene. Despite the beneficial effect on L-arginine on muscle weakness and fo[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Arnold AS ; Handschin C | 2008Spinal muscular atrophy (SMA) is characterized by a mutation in the survival motor neuron (SMN) gene, leading to a deficit of expression of the SMN protein, a ubiquitously expressed protein which exact function is unknown. It results in motoneur[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Hutchison C ; Salpingidou G ; Markiewicz E | 2008Emerin is a type II integral membrane protein of the inner nuclear membrane and was the first nuclear membrane protein to be implicated in muscular dystrophy. Mutations in the gene STA, which encodes emerin, underlie the X-linked form of Emery D[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Aebischer J ; Moumen A ; Pettmann B ; Raoul C | 2008Death pathways restricted to specific neuronal classes could explain the selectivity of neuronal loss in neurodegenerative diseases, such as the loss of motoneurons in amyothrophic lateral sclerosis (ALS). We previously showed that Fas-induced d[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Gotic I ; Naetar N ; Biadasiewicz K ; Stewart C ; Foisner R ; Perutz MF | 2008Lamina-Associated Polypeptide 2 (LAP2) alpha belongs to a family of nucleoskeletal proteins that bind to chromatin and lamins. While the majority of lamins forms a scaffolding network at the nuclear envelope supporting nuclear architecture, A-ty[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Jeannet PY ; Spehrs-Ciaffi V ; Aminian K ; Paraschiv-Ionescu A | 2008While new therapies for neuromuscular disorders are being investigated, it is also important to develop new tools to quantify the potential effects of such therapies. Devices recording the patient’s daily physical activity in their natural envir[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Mercuri E | 2008Increasing attention has been devoted in the last few years to the use of functional scales and other assessments of muscle function and strength in neuromuscular disorders. A range of good functional outcome measures already exist which are rea[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Parolini D ; Meregalli M ; Belicchi M ; Farini A ; Razini P ; Maciotta S ; Torrente Y | 2008Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease due to a deficiency in dystrophin, a 427kDa protein located at the sarcolemma and acting as a linker between cytoskeleton and extracellular matrix Several observations sugg[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Desguerre I ; Christov C ; Mayer M ; Zeller R ; Bécane HM ; Leturcq F ; Chelly J ; Gherardi R | 2008Innovative therapies are presently being developed for DMD. Evaluating their effect will require precise knowledge of both the natural history and factors influencing the course of a disease which can be no longer considered as homogeneous in te[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Thorel D ; Méchin D ; Beroud C ; Rivier F ; Coubes C ; Jouk PS ; Leturcq F ; Cossee M ; Tuffery-Giraud S ; Claustres M ; Khau Van Kien P | 2008In the families with a reported case of dystrophinopathy, pedigree analysis with measurement of blood creatine phosphokinase (CK) are commonly used for genetic risk assessment of relatives. Several affected cases in the same family across genera[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Llorens A ; Diaz-Ramos MA ; Lopez-Alemany R | 2008The Plasminogen Activation (PA) system is a group of serin-proteases that plays an important role in a wide range of biological processes in which tissue remodelling takes place. Plasmin, generated by activation of its zymogen plasminogen, is a [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Paushkin S | 2008PTC Therapeutics, Inc. (PTC) has established a new program to identify compounds that modulate the levels of the survival of motor neuron (SMN) protein at the post-transcriptional level. The program is driven by three innovative approaches. The [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; van Deutekom JCT ; de Kimpe SJ ; Ekhart PF ; van den Akker JTHM ; Sitsen JMA ; Janson JAM ; de Winter C ; Aartsma Rus A ; van Ommen GJB ; Verschuuren JJM ; Goemans NM ; Platenburg GJ | 2008Duchenne muscular dystrophy (DMD) patients suffer from a progressive, severe muscle-wasting disease due to frame-disrupting mutations in the DMD gene and a complete loss of functional dystrophin. Antisense oligonucleotide compounds (AONs) have r[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Sweeney HL | 2008Nonsense mutations promote premature translational termination and cause anywhere from 5 to 70% of the individual cases of most inherited diseases. To address the need for a drug capable of suppressing premature termination, we developed PTC124,[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Skuk D ; Paradis M ; Goulet M ; Tremblay J | 2008Duchenne muscular dystrophy (DMD) is characterized by a progressive destruction and ultimate disappearance of the skeletal muscle parenchyma, which is replaced by adipose and fibrous connective tissue. Previous reports about the involvement of n[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Devaux C | 20081 - Spécificité des maladies neuromusculaires > Les patients neuromusculaires ont des muscles malades mais des poumons sains, quand ils ont bénéficié de manière précoce : - d'une kinésithérapie respiratoire avec aide instrumentale, favorisant l[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Attarian S ; Pouget J ; Schmied A | 2008In view of the conflicting results about the links between lower and upper motor neurons (LMN, UMN) dysfunction in amyotrophic lateral sclerosis (ALS), our objective was to correlate their changes over time. Single motor units (MUs) were charact[...]Reco PNDS
Sommaire : - Les conditions d'élaboration du premier rapport de la CNS - Les enseignements des rapports régionaux - Neuf propositions pour une action résolue des pouvoirs publics dans la promotion et la défense des droits des usagers.Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Amthor H | 2008A powerful inhibition of muscle growth is exerted by myostatin, a member of the TGF-ß family of signalling molecules. Loss of myostatin after gene knockout results in the excessive growth of skeletal muscle. Despite a larger muscle mass of myost[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Mondin L ; Sebille S ; Balghi H ; Constantin B ; Raymond G ; Cognard C | 2008Evidence is presented for the involvement of IP3-dependent release calcium pathway in the contribution of calcium overload in dystrophin-deficient cells. Our previous results presented that global calcium release during stimulation (K+-evoked ca[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Renvoisé B ; Hamaï S ; Montagne JJ ; Gendron MC ; Lefebvre S | 2008Spinal muscular atrophy (SMA) is caused by mutations of Survival Motor Neuron 1 (SMN1) gene, which lead to reduction of SMN protein levels. The ubiquitous SMN complex participates to the biogenesis of spliceosomal core snRNPs and together are en[...]Article
Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Rose MR | 2008Il existe plusieurs motivations à l'augmentation de l'intérêt pour l'évaluation de la qualité de vie (QdV) dans les maladies chroniques de longue durée telles que les maladies neuromusculaires (MNM). De nombreuses MNM ne peuvent pas être soignée[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Jeannet PY ; Spehrs-Ciaffi V ; Aminiank K ; Paraschiv-Ionescu A | 2008Alors que de nouveaux traitements des troubles neuromusculaires sont à l'étude, il est également important de développer de nouveaux outils visant à quantifier les effets potentiels de ces traitements. Des appareils enregistrant l'activité physi[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Halter B ; De Aguilar GJL ; Fricker B ; Rene F ; Deroide N ; Petri S ; Echaniz-Laguna A ; Dengler R ; Loeffler JP | 2008Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset neuromuscular disease characterized by selective degeneration of upper and lower motor neurons, progressive muscle wasting, and paralysis. Some familial cases are caused by missense muta[...]Livre
Responsabilité professionnelle : scolariser tous les élèves (15 Février 2007; Paris (La villette)) ; Aymonier ; Lerch D ; Galy B ; Crucq R ; Prost | Suresnes : INS-HEA | 2008Les actes de ce colloque sont présentés en trois parties. 1ère Partie : - Allocution d'ouverture par le Président de la FAS & USU et le Directeur de l'INS-HEA ; - Conférence plénière : Scolarisation obligatoire et handicaps de France de 1882 à 2[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Berbey C ; Weiss N ; Legrand C ; Allard B | 2008A Ca2+ influx is known to occur in skeletal muscle cells at rest. The study of this influx is of primordial interest since an exacerbated resting Ca2+ entry has been considered to represent an early step associated with the pathophysiological ch[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Finkel R ; Bertini E | 2008Hypothesis: Parental surveys in pediatric neuromuscular disorders provide useful data when considering clinically meaningful responses to treatment, generating standard of care guidelines and in designing effective clinical trials. Design/Method[...]Article
Highlights of the 60th Annual Meeting of the American Academy of Neurology (April 12-19, 2008; Chicago, Illinois) ; Culebras A ; Kelly JJ | 2008Accès au résumé PubMed / to PubMed abstractArticle
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Durand S ; Pomiès P ; Fabbrizio E ; Lejeune F ; Bonet-Kerrache A | 2008Duchenne muscular dystrophy (DMD) is a severe X-linked muscle degenerative disease caused by mutations or deletions in the dystrophin gene leading to absence of the protein. The members of the Rho family of small GTPases are molecular switches t[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Attia M ; Huet E ; Ledoux D ; Menashi S ; Martelly I | 2008INTRODUCTION La régénération musculaire nécessite un remodelage de la matrice extracellulaire sous l'action des métalloprotéinases matricielles (MMP). Des études récentes montrent qu'EMMPRIN/CD147 est un inducteur de ces protéinases. OBJECTIFS L[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Dhamane E ; Gallo C ; Petermann O ; Roulet E | 2008Calcium dysbalance is expected to be one of the triggering events causing muscular degeneration in Duchenne muscular dystrophy (DMD). It has been proposed that the increased Ca2+ influx could result from transient membrane lesions (Menke et al.,[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Nishino I | 2008RYR1 has been associated with central core disease, in addition to multiminicore disease and malignant hyperthermia (MH). However, the frequency of RYR1 mutations in central core disease and its genotype-phenotype correlation was not clear. Our [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Finkel R | 2008The ideal scale for the assessment of a patient with a neuromuscular disorder incorporates functionally meaningful items, can be administered briefly and without expensive equipment by trained evaluators, is sensitive to change within a six to t[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Walter MC | 2008In 1965, an adult-onset, autosomal dominant disorder with a peculiar scapuloperoneal distribution of weakness and atrophy was described in a large, multi-generation kindred and named 'scapuloperoneal syndrome type Kaeser'. By genetic analysis of[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Colasse S ; Khoobarry K ; Renvoisé B ; Lefebvre S | 2008Infantile spinal muscular atrophy (SMA) is an inherited disorder characterized by the degeneration of spinal motor neurons and progressive muscular atrophy. There is no cure for SMA. The SMA disease is caused by mutations of the survival motor n[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Saugier-Veber P ; Vezain M ; Melki J ; Toutain A ; Bieth E ; Husson M ; Pedespan JM ; Viollet L ; Pénisson-Besnier I ; Frebourg T ; Tosi M | 2008Different therapeutic strategies are currently evaluated in spinal muscular atrophy (SMA) that are aimed at increasing full-length (FL) mRNA levels produced from the SMN2 gene. Of course, an inverse correlation between SMN2 copy number, SMN prot[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Candelario-Martínez A ; Rodriguez Munoz R ; Mornet D ; Martinez-Rojas D | 2008Syntrophins are a family of scaffolding proteins with multiple domains that link signalling proteins to dystrophin family members (Dp71 in brain). Syntrophins can interact simultaneously with multiple proteins via two pleckstrin homology domains[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Richard A ; Niro C ; Demignon J ; Giordani J ; Grifone R ; Guillet-Deniau I ; Bajard L ; Daubas P ; Buckingham M ; Maire P | 2008Six proteins preferentially accumulate in the hypaxial myogenic progenitors of the dermomyotomes in the mouse embryo, and in the adult SIX proteins preferentially accumulate in the nuclei of fast/glycolytic muscle fibre. To understand the functi[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Li Z ; Kollias H ; Wagner K | 2008Myostatin is a TGF-? family member that negatively regulates muscle growth. Studies in a mouse model of Duchenne and Becker muscular dystrophy (mdx) showed that deletion of myostatin gene or treatment with a postnatal inhibitor of myostatin sign[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Marcelle C ; Gros J ; Manceau M | 2008In amniotes, all skeletal muscles of the body and the limbs derive from mesodermal embryonic structures, named the somites. We utilize the electroporation of fluorescent reporter genes (e.g. GFP) in somites of chick embryos, combined with video-[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Bernheim L | 2008Postnatal myogenesis, which occurs during muscle repair after a lesion, relies on the activation of myogenic stem cells (muscle satellite cells). Activated satellite cells proliferate as myoblasts that have the ability of migrating to the lesion[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Paquette B ; Coté J | 2008Deletions or loss-of-function mutations in the Survival of Motor Neurons 1 (Smn1) gene in humans is responsible for Spinal Muscular Atrophy (SMA), one of the leading genetic causes of infant mortality. The pathological hallmarks of this disease [...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Koulmann N ; Richard-Bulteau H ; Gangloff YG ; Banzet S ; Pasdeloup M ; Schaeffer L ; Bigard X | 2008INTRODUCTION mTOR joue un rôle central dans la régulation de la masse musculaire. Son absence dans le muscle squelettique conduit à des altérations importantes des capacités oxydatives et de l'expression de gènes du métabolisme énergétiqu OBJECT[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Amarof K ; Inamo J ; Sarrazin E ; Deschamps R ; Smadja D ; Bellance R | 2008Spinal muscular atrophy (SMA) is a recessive disorder characterized by degeneration of motor neurons in the anterior horn cells of the spinal cord and the brainstem, and with, clinically progressive weakness and hypotonia. The most common SMA is[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Bigard X ; Koulmann N | 2008Toutes les situations anabolisantes se caractérisent par la production locale d'IGF-1 et l'activation de la voie PI3K/Akt/mTOR ; cette voie de signalisation est impliquée dans le contrôle de la traduction non-sélective des transcrits, mais c'est[...]Article
Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Ruegg U | 2008Duchenne Muscular Dystrophy (DMD) patients show muscular weakness, that progresses towards paralysis and leads to death at age 20-30. DMD patients usually die in the third decade because of respiratory or cardiac failure. DMD is caused by mutati[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Rochcongar P | 2008L'administration de corticoïdes est susceptible d'entraîner à moyen terme une perte de force et une fatigabilité musculaire. Les corticoïdes, largement utilisés par les sportifs, ont un effet systémique, quel que soit le mode d'administration. S[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Legardinier S ; Hubert JF ; Le Bihan O ; Tascon C ; Rocher C ; Raguénès-Nicol C ; Bondon A ; Hardy S ; Le Rumeur E | 2008Dystrophin is a muscle scaffolding protein that establishes a structural link between the cytoskeleton and the extracellular matrix. Despite the large body of knowledge about the dystrophin gene and its interactions, the functional importance of[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Nakae Y ; Hirasaka K ; Goto J ; Nikawa T ; Shono M ; Yoshida M ; Stoward PJ | 2008Dystrophic muscles suffer from enhanced oxidative stress. We have investigated whether administration of an antioxidant, epigallocatechin-3-gallate (EGCG), a major polyphenol of green tea, reduces their oxidative stress and pathophysiology in md[...]Article
A synthetic mechano growth factor E peptide enhances myogenic precursor cell transplantation success
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Mills P ; Dominique JC ; Lafreniere JF ; Bouchentouf M ; Tremblay JP | 2008Duchenne muscular dystrophy (DMD) is the most frequent dystrophy by affecting 1 male on 3500 all around the world. Cellular therapy is one of the promising potential treatments for this disease although it faces some problems. Growth factors, su[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Vitiello C ; Auricchio A ; Faraso S ; Sorrentino N ; Nusco E ; Nigro G ; Di Salvo G ; Calabro R ; Di Napoli D ; Castaldo S ; Nigro V | 2008Limb-girdle muscular dystrophies 2C-2D-2E-2F (LGMD2C-2F) are classified as "sarcoglycanopathies" and represent the most severe forms, often associated with cardiomyopathy They are caused by mutations in any of the four sarcoglycan (?, ?, ? and ?[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Yin H ; Seow Y ; Moulton HM ; Iversen PL ; Boutilier JK ; Wood MJA | 2008Duchene Muscular Dystrophy (DMD) is a severe muscle disorder caused by mutations in the dystrophin gene. The efficacy of antisense oligonucleotide (AO)-mediated exon skipping for the restoration of dystrophin has been established in animal model[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Puymirat J ; Doucet G ; Huguet D ; Hiba B ; Gourdon G ; Furling D ; Janier M | 2008DM1 is caused by the expansion of a CTG repeat in the 3’untranslated region (3’-UTR) of a protein kinase (DMPK), which map to 19q13.3. There is accumulating evidence that the CTG repeat causes titration and sequestration of specific RNA-binding [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Pandya S ; Dilek N ; Martens W ; Moxley R | 2008Objective : To establish the test- retest reliability of DEXA measurements in patients with DMD. Background : DEXA measurements are frequently used as an outcome measure in therapeutic trials of DMD to document changes in lean body mass. There i[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Morel JL ; Fritz N ; Dabertrand F ; Macrez N ; Henaff M ; Mironneau J ; Mironneau C | 2008The mdx mouse, a model of the human Duchenne muscular dystrophy displays incompletely understood impaired contractile function of skeletal, cardiac and smooth muscles. We explored the possibility that ryanodine receptor (RYR) expression could be[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Apostol P ; Cimponeriu D ; Stavarachi M ; Butoianu N ; Minciu I ; Burloiu C ; Toma M ; Magureanu S ; Gavrila L | 2008Background Skeletal muscle dysfunction is the main clinical feature in patients with different types of spinal muscular atrophy (SMA). We consider that improper muscle irrigation could accelerate the progression of muscular dysfunction in these [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Bérard C ; Payan C ; MFM study group | 2008Following a questionnaire sent in 1998 to international teams concerning the need of a new functional scale suited to neuromuscular diseases, the Motor Function Measure (MFM) was constructed and validated. Three successive versions and more than[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Eagle M ; Scott E | 2008The North Star Clinical Network for Paediatric Neuromuscular Disease Management (NSCN) is a collaboration of neuromuscular centres in the UK whose aim is to optimize the management of children with neuromuscular disorders. One of the initial key[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Schröder R | 2008Plectin, a high molecular weight cytoskeletal linker protein (530 kDa), is widely distributed in mammalian tissues, with highest expression in squamous stratified epithelia, muscle and brain. Mutations of the human plectin (Plec1) gene on chromo[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Siegel A ; Zimmerman A ; Henley S ; Rhodes J ; Miles M ; Shin G ; Beck B ; Hoff H ; Kurz J ; Balch F ; Carlson CG | 2008The TS is an expiratory muscle that is passively stretched with each inspiration and concentrically activated with each expiration. The degree of passive stretch of TS muscle fibers depends upon the location of the fiber within the muscle, with [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Rimessi P ; Sabatelli P ; Braghetta P ; Fabris M ; Bassi E ; Spitali P ; Vattemi G ; Perrone D ; Medici S ; Neri M ; Bovolenta M ; Martoni E ; Maraldi N ; Bonaldo P ; Gualandi F ; Merlini L ; Caputo A ; Tondelli L ; Laus M ; Ferlini A | 2008For a subset of Duchenne muscular dystrophy (DMD) mutations, antisense oligonucleotide (AON)-mediated exon skipping has been reported to be efficacious to restore protein expression. The primary goal of our study was to evaluate the usage of nov[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Stuelsatz P ; Veschambre P ; Cottin P | 2008MyoD is part of the myogenic regulatory factors (MRFs) family, which are the essential factors controlling the myogenesis during embryonic development or muscular regeneration in the adulthood. CAPN3 is a calcium-dependent cysteine protease main[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Blazquez L ; Azpitarte M ; Saenz A ; Goicoechea M ; Otaegui D ; Vilchez J ; Lopez de Munain A | 2008Introduction: Limb-girdle muscular dystrophy type 2A (LGMD2A) is an autosomal recessive disorder caused by mutations in the CAPN3 gene. This gene is preferentially expressed in muscle tissue, but we have recently described that four different CA[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Udd B | 2008The first human titinopathies were identified in 2002. Five years later there is a wide variety of clinical phenotypes and mutational defects involved with titin mutations, such as selective cardiomyopathy, selective distal myopathy, LGMD phenot[...]Article
Mesoangioblasts are recently characterized progenitor cells associated with the vasculature and able to differentiate in different types of solid mesoderm including skeletal muscle. Human adult mesoangioblasts were recently isolated and expanded[...]Article
5e Congrès international de rééducation dans les maladies neuromusculaires (5th international rehabilitation conference in neuromuscular diseases; 30 mai - 1er juin 2008; Marseille, France) ; Baticle M ; Thémar-Noël C | 2008Toute douleur doit faire l'objet d'une recherche étiologique : nociceptive, neuropathique, psychologique, idiopathique. Elle doit être évaluée systématiquement avant toute décision thérapeutique. Pour cela, il faut s'aider des différents outils [...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Pêcheux C ; Krahn M ; Chapon F ; Beroud C ; Drouin-Garraud V ; Laforet P ; Romero NB ; Pénisson-Besnier I ; Bernard R ; Urtizberea JA ; Leturcq F | 2008Mutations in the gene encoding calpain-3 (CAPN3) cause autosomal recessive Limb-Girdle Muscular Dystrophy type 2A (LGMD2A) and idiopathic Eosinophilic Myositis. Accurate diagnosis and genetic counselling is based on the identification of disease[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Bushby K ; Lynn S ; Straub V | 2008Promising therapies for neuromuscular diseases have been identified from many research areas and clinical trials for some of these therapies have begun. These long awaited developments have illustrated the lack of trial readiness amongst the neu[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Louis M ; Zanou N ; Gailly P | 2008Myoblasts migration is a key step in myogenesis and in regeneration. It allows myoblasts alignment and fusion into myotubes. This process has been shown to involve m- or µ-calpains, two calcium-dependent cysteine proteases. Indeed, growth factor[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Legardinier S ; Legrand B ; Raguénès-Nicol C ; Bondon A ; Le Rumeur E ; Hubert JF | 2008While dystrophin's native function is still largely unknown, it is well established that lack of functional dystrophin in muscle cell causes Duchenne muscular dystrophy (DMD). The native dystrophin is organised in four domains: a N-terminal acti[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Fischer U ; Chari A ; Neuenkirchen N ; Giegerich M ; Klingenhaeger M ; Winkler C | 2008Spinal muscular atrophy is a neuromuscular disease caused by reduced levels of the survival motor neuron (SMN) protein. SMN is part of a macromolecular ("SMN")-complex that, together with the PRMT5-complex mediates the assembly of Sm proteins on[...]Article
VIes Journées annuelles de la Société Française de Myologie (SFM) (22-23 octobre 2008; Lausanne (Suisse)) ; Gherardi RK ; Chrétien F ; Bassez G ; Authier FJ ; Tajbakhsh S ; Chazaud B ; Christov C | 2008INTRODUCTION La régénération musculaire est un processus hautement intégré faisant intervenir l'activation des cellules satellites (CS), quiescentes sous la basale des myofibres, et leur interaction avec des cellules non myogéniques OBJECTIFS L'[...]Article
Livre
Multimédia
Publication AFM
Intégré aux Vèmes Journées annuelles de la Société Française de Myologie, le symposium Genzyme intitulé " Maladie de Pompe : des myopathies métaboliques à l'enzymothérapie " a, notamment été l'occasion de présenter le Registre Français de la mal[...]Publication AFM
Brignol TN, Auteur ; Brignol TN | 12/2007DM1 : compliance au traitement Le défaut de compliance au traitement est un risque chez les patients atteints de DM1. En connaître les principaux facteurs permettrait au clinicien de détecter les patients à risques et d'agir préventivement afi[...]Publication AFM
Colloque sans nom (4ème conférence européenne sur les maladies rares; 27-28 novembre 2007; Lisbonne) | 12/2007Organisée par Eurordis à Lisbonne, la 4e Conférence Européenne sur les Maladies Rares a été, pour les personnes atteintes de ces maladies et leurs représentants, les professionnels de santé et les décideurs politiques, l'occasion de débattre ave[...]Publication AFM
Rapport institutionnel
Améliorer la qualité de vie des personnes handicapées en Europe : participation pour tous, innovation, efficacité (21-22 Septembre 2006; Saint Pertersbourg, Fédération de Russie) | Strasbourg : Conseil de l'Europe | 12/2007Actes de la conférence qui s'est tenue à Saint Pertersbourg, Fédération de Russie, le 21 et 22 septembre 2006. Ce colloque était organisé par la Direction Générale de la cohésion sociale du Conseil de l'Europe. Les 2 thèmes principaux portaient [...]Article
Vallet P | 12/2007Après la parution de la loi du 11 février 2005, l'AFM prend l'initiative de générer un débat large avec des associations représentatives et des professionnels autour d'une question "Acquisition d'une aide technique : quel processus, quels acteur[...]Livre
Colloque à mi-parcours des projets financés par l'ANRLivre
Publication AFM
Collectif, Auteur | 09/2007Texte intégral de l'article Le 4e Symposium International sur la Fibrodysplasie Ossifiante Progressive (FOP), intitulé " Ensemble, Nous Pouvons Bouger des Montagnes ", s'est tenu à Orlando (USA) du 16 au 19 août 2007. Dédié à la découvert[...]Publication AFM
Roux JC | 09/2007Texte intégral de l'article En 2008, une journée commune fera le trait d'union entre deux congrès concernant les maladies neuromusculaires (MNM). En effet, Myologie 2008 (3e Congrès International de Myologie) et le 5e Congrès Internationa[...]